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METHODOLOGY PAPER
ABSTRACT
Background: Social Prescribing (SP) is an intervention to link users of the primary 
healthcare services to non-clinical organizations based on the community to tackle 
social determinants of health. Despite the potential benefits of SP, the effectiveness of 
this complex intervention remains uncertain. This paper presents the study protocol of 
the evaluation of the first SP project in Portugal. 
Methods: A mixed-methods study will be conducted to evaluate the SP project. For the 
quantitative component, a longitudinal, prospective study with a pre-post design will 
be performed. Data on patients referred to SP will be collected in four different points in 
time throughout the intervention, using questionnaires on patients’ health status and 
sociodemographic characteristics, and scales on patients’ well-being, quality of life and 
activation. The secondary data will be collected using patients’ medical records and 
SP’s forms about the referral and social responses elaborated within the intervention. 
Semi-structured interviews with patients and focus groups with stakeholders will be 
conducted to assess experiences of participation and improvement suggestions on SP. 
Conclusion: Comprehensive and complementary evidence will provide insights and 
learning for the implementation of future SP interventions. This can contribute to inform 
policy and practice, and to increase investment in social prescribing interventions.
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BACKGROUND
The health of individuals is broadly acknowledged to be 
influenced by a combination of multilevel interrelated 
determinants – genetic, psychological, lifestyles, 
ecosystems, as well as social, economic, cultural and 
structural (including healthcare system) [1]. These 
multiple complex factors, along with daily life contexts, 
frequently translate into health inequities [1]. 
It has been evidenced that situations of loss of 
employment, poor social and economic resources, social 
isolation, interpersonal problems, or illness of a relative can 
trigger the manifestation of physical symptoms, stress, 
depression, anxiety [2]. Moreover, situations of social 
exclusion and economic disadvantage are associated with 
low levels of health literacy, less means for healthy lifestyle 
habits and decreased access to healthcare, that can lead 
to non-communicable diseases, and, consequently, to 
higher mortality and lower life expectancy [3–5]. In these 
cases, an exclusively clinical approach may not be the 
most appropriate response [2, 6]. 
Social Prescribing (SP) has a potential role in effectively 
tackling social determinants of health and in preventing 
exacerbation of pre-existing diseases, with the purpose 
of improving users’ health and well-being [6, 7]. SP is a 
complex intervention and a solution to respond to non-
clinical needs of individuals and to articulate healthcare 
with other sectors of society [6]. This intervention has 
been considered an innovative public health approach 
that allows the provision of integrated care by linking 
healthcare services to the tertiary sector, and thus 
providing more than solely traditional health care [8–
9]. Furthermore, SP can contribute to reduce inequities 
by covering and addressing the needs of vulnerable 
populations (such as migrants, individuals with mental 
illness, or at risk of social isolation) [10–12]. 
The process of SP starts with the identification of a 
patients with social, emotional or practical needs by a 
health professional. These patients include people with 
one or more chronical medical conditions, who have 
complex social needs which affect their health and well-
being, who are lonely or isolated, or who need support 
related to mental health [10]. The health professional 
refers the patient to a link worker, who is responsible for, in 
a SP appointment, assessing the patient’s needs in detail 
and developing a tailored plan of activities in collaboration 
with the patient [13]. The link worker is a key professional 
in the SP process and provides personalised support to 
individuals, connecting people to community groups and 
statutory services [10]. Some of the link worker skills are 
ability to listen, ability to support people in a way that 
inspires trust and confidence, ability to communicate 
effectively with all stakeholders, and commitment to 
collaboratively working with all local agencies [10]. The 
link worker helps patients and their carers to navigate the 
voluntary and community services [8]. 
Based on the identified needs and the co-designed 
plan, the patient may be referred to a diverse set of 
social responses from the community resources, such 
as physical activities, dance groups, arts and crafts, 
professional training, education activities, food bank 
support, day-care centre, volunteering, among others. 
These responses can be provided by different institutions, 
including local authorities, social services, community 
and voluntary organizations [10]. 
SP has been broadly implemented in the English 
National Health Service (NHS) as an intervention of the 
NHS Long-Term Plan since 2019 [10, 14]. One of the 
few randomized clinical trials conducted to evaluate 
SP has showed improvements in anxiety, pain and self-
rated overall health, although no significant changes 
in depression levels. Higher prescription of medications 
and higher costs were also found in the intervention 
group [15]. Another study conducted in the United 
Kingdom evidenced an increase of self-reported physical 
activity, a better self-perception of quality of life, well-
being and lower BMI in patients enrolled in SP activities. 
Nevertheless, the authors did not found differences 
in frequency of alcohol consumption and smoking 
status among these patients [16]. Other studies also 
seem to indicate that SP has the potential to promote 
empowerment and activation for health, in terms of 
increased knowledge, confidence, motivation and ability 
of the users to self-manage their health [17, 18].
The available research does not provide consistent 
evidence on the impact of SP. Several studies do not 
present significative differences in anxiety, depression 
and well-being levels between control groups and 
groups of patients enrolled in SP [11, 19]. Furthermore, 
a lack of significative differences in SP’s impact between 
baseline and follow-up evaluation moments has also 
been evidenced [20]. The main limitations presented in 
these studies are small sample sizes, no use of inferential 
statistics and low response rates to the evaluation 
instruments, which compromises the quality of the 
evidence provided [11].
Evidence on the provision of integrated care and 
networking in SP interventions is scarce, although some 
policy reports suggest that SP may reinforce the proximity 
between the social and healthcare sectors by having the 
participation of local organizations in SP as key-partners in 
the implementation of personalized, local and preventive 
activity plans for the patients [10]. Other publications 
report that SP can also increase the patients’ sense of 
belonging to the community, in addition to fostering a 
more efficient local economy [6, 11]. 
In terms of the health system, although contradictory 
results are often found, some studies indicate that SP 
can have an impact in the reduction of the number of 
appointments with a General Practitioner (GP) and in 
decreased prescription of antidepressant, hypnotic, and 
anxiolytic medicines for patients enrolled in this type of 
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intervention [10, 21]. Other research shows a greater 
workload of professionals involved in SP and higher costs 
of referral to this intervention [11]. 
SP evaluation studies are still incipient and present 
controversial results. When it comes to the evaluation of 
SP, a variety of studies has been performed, comprising 
randomized controlled trials, case-control studies, 
case studies, qualitative studies, among others, that 
used various data collection instruments applied with 
different periodicities, and measured different outcomes 
[19, 20, 22–25]. Indeed, although the wider health 
benefits of the SP intervention, such as improve patients’ 
health, well-being and quality of life, should be covered, 
other outcome measures can be added according to the 
specific objectives of each intervention [10, 20]. Thus, this 
heterogeneity poses a great challenge when designing 
SP evaluation studies [20, 26, 27]. In addition, since SP 
is a complex intervention, evaluation studies that give 
insights on its impact for the patients, for the health 
system and for the community would be valuable [10]. 
SP IN PORTUGAL
The first SP project in Portugal was launched in two 
Primary Healthcare Units – Baixa and Almirante Family 
Health Units – located in central Lisbon and provide 
healthcare to approximately 27500 patients with a 
high variability of sociodemographic characteristics. All 
users registered in these Primary Healthcare Units can 
be referenced to SP, except patients with severe and 
uncontrolled mental health issue.
The intervention starts when a healthcare professional 
(general practitioner, nurse or psychologist), during 
an appointment with a patient, identifies social needs, 
namely related to social isolation, migrant integration, 
mental health, physical activity, employment and 
training, or housing issues. After that, the healthcare 
professional makes an internal referral through an 
SP online platform to the link worker, which in the 
Portuguese context is the unit’s social worker. In this 
platform the healthcare professional fills in the reasons 
for referral, presence of chronic diseases and brief history 
of the patient. Afterwards, the patient is encouraged to 
schedule a SP appointment with the social worker to 
continue the support of SP. 
In the SP appointment, the social worker performs 
a needs assessment and helps patients to identify the 
issues that impact on their health and well-being. Then, 
the social worker develops a tailored intervention plan 
in collaboration with the patient, based on the person’s 
priorities, interests, values and motivations [10]. This plan 
foresees an external response provided by community 
partners from the health unit’s geographical area or 
according to the patient’s preference.
In the next stage of the SP pathway, the social 
worker refers the patient to the key community 
partners. Communication between the social worker 
and community partners is made by e-mail containing 
information about the patient’s needs and the social 
partner’s availability of response, and through online 
forms to monitor the activities in which the patient is 
participating and the frequency of adherence. 
Throughout SP intervention, the social worker 
communicates with the patient through face-to-
face SP appointments or phone calls to follow the 
compliance and satisfaction with the activity plan, 
and communicates with the healthcare professional 
to give feedback on the patient´s case. The number of 
appointments with the link worker depends on each 
user’s needs, but as documented elsewhere, the SP 
intervention takes around 4–6 appointments per patient 
[16, 28], although, if necessary, more follow-ups can be 
scheduled. The average length of the appointments is 30 
minutes.
Overall, the SP intervention changed the conventional 
role of the social worker in Health Units in Portugal. Health 
professionals usually referred patients to the social work 
service when the issues were mainly associated with 
administrative issues in access to social and health 
benefits, such as support to buy medicines, functional 
dependency or end of life support. SP intervention 
allowed to expand the role of the social worker within 
primary care to include: advice and support on lifestyle 
changes (physical activities, food habits), community 
engagement, employment and training, mental health 
promotion, personalised emotional and social support, 
as well as connect people to community groups and 
statutory services.
RESEARCH AIMS
The aim of this protocol is to evaluate the SP intervention 
implemented in Primary Healthcare Units of Lisbon, with 
a focus on patients’, health-social sector collaboration, 
and health system’ levels.
The specific objectives are to: I) Explore the extent 
to which the SP intervention leads to enhance patients’ 
quality of life, well-being, and activation; II) Explore 
experiences of patients during their participation on 
SP activities, including positive and negative aspects, 
and suggestions for improvement; III) Understand the 
implementation of SP from the perspectives of health 
professionals, social workers, and community partners; 




This evaluation protocol will use a mixed-methods 
approach consisting of four studies, each one addressing 
a specific objective, as illustrated in Figure 1. 
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Study 1 – Evaluating the quality of life, well-being 
and activation of patients in SP over time
Design and participants
In order to explore the extent to which the SP intervention 
leads to enhance patients’ quality of life, well-being 
and activation, a pilot study will be conducted, with 
an exploratory, longitudinal and prospective design, 
comprising four assessment moments: baseline, follow-
up 1 (third month), follow-up 2 (sixth month) and follow-
up 3 (twelfth month) (Figure 2). 
The sample will include all the patients referred 
for the first time to a SP appointment who fulfil the 
inclusion criteria: being ≥18 years old and living in Lisbon. 
Patients who are terminally ill, who present severe and 
uncontrolled mental health issues (e.g. uncontrolled 
schizophrenia, acute psychosis), who are housebound, 
and who present uncontrolled use of drugs and/or 
alcohol are excluded from participation in the study. A 
recruitment target is estimated at 300 patients, with the 
chances of non-acceptance of participation and losses to 
follow-up (attrition rate) being estimated at >20%, based 
on previous studies [15, 19, 20, 28]. 
All patients referred to SP in the first 12 months will 
be included in the baseline and the data collection will 
be conducted during 24 months. Both the patients 
who undertake SP activities and those who end their 
participation during data collection period will be 
included in the follow-ups. 
Data collection 
Before the first SP appointment, the patient will be invited 
to participate in the study (baseline) and will be asked to 
provide a written informed consent. Table 1 summarizes 
the instruments and measures used for data collection 
throughout the assessment moments.
A questionnaire will be applied to collect data on: I) 
Sociodemographic characteristics (sex, age, country of 
birth, educational level, employment status, number of 
people in the household, average monthly income of the 
household and preferred language); II) Health status 
(height and weight, physical activity, smoking behaviour, 
and alcohol consumption); III) Mental well-being 
(using the Warwick-Edinburgh Mental Well-being Scale 
– WEMWBS); IV) Patient activation (through 13-item 
patient activation measure – PAM13); and V) Quality of 
life (using the EuroQol 5 dimensions instrument – EQ-5D-
3L). Prior authorization for the use of each of the scales in 
Portuguese and English versions was obtained. 
Figure 1 Description of the studies and objectives.
Figure 2 Moments of assessment.
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The questionnaire was tested in a purposive sample 
of patients not enrolled in the study. As a result, the 
guidelines for filling the questionnaire were simplified in 
order to ensure clarity of the information.
In addition to the questionnaire, secondary data 
will be collected from patients’ medical records. This 
data will consist of indicators related to the use of 
healthcare services (number of appointments in the 
Primary Healthcare Units, of hospital admissions, and 
of emergency episodes) and health status (number 
and types of chronic diseases, and medications 
consumption). 
In the follow-ups, data will be collected using the same 
instruments of baseline. The questionnaire will be applied 
in the health unit before the SP appointments. In order 
to ensure the inclusion of people with low literacy and 
educational levels or that experience difficulties with self-
administration, the questionnaire will be administered by 
a researcher through an interview (either in Portuguese or 
in English). In situations where the patient has interest in 
participating in the study but is unable to communicate 
in Portuguese or English, or has learning disabilities and 
other types of disabilities, a person that accompanies 
the patient can help in collecting the information, with 
the consent of the patient and when applicable. A 
unique alphanumeric code will be used to identify each 
participant in all evaluation instruments throughout the 
longitudinal assessment moments.
Additional information about the SP intervention will 
comprise data on the type of health professional that 
made the referral and motive for signposting (from 
the SP form filled in by the health professional) and 
information about the SP activities provided, accepted 
and programmed, and patient’s adherence to the 
activities (through the online forms filled in by the 
community partners).
Data analysis 
The primary outcome measures comprise the levels of 
quality of life, well-being and the patients’ activation. 
The sociodemographic characteristics, health status, 
use of healthcare services and characteristics of the 
intervention are considered the secondary outcome 
measures. A statistical analysis will be conducted to 
analyse the association between primary and secondary 
outcomes. Furthermore, comparative measures between 
the baseline and follow-up 1, 2 and 3 will be computed, 









up 1, 2 and 3




– Country of birth
– Educational level
– Employment status
– Number of people in the household
– Average monthly income of the household
– Preferred Language





Patient’s activation – PAM13
Quality of life – EQ-5D-3L
Computer system Health units’ 
Databases
Health status – Number of chronic diseases
– Types of chronic diseases
– Medications consumption
Use of healthcare 
services
–  Number of appointments in the Primary 
Healthcare Services 
– Number of hospital admissions 
– Number of emergency episodes







Forms Characterization of 
the intervention
–  Type of health professional that made the 
referral 
– Motive for referral 
– Activities provided 
– Accepted and planned activities 
– Adherence to the activities 
Table 1 Summary table of the evaluation’s quantitative component.
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analyses will be conducted using the IBM SPSS Statistics 
software, in the most recent version available.
Study 2 – Exploring experiences and suggestions 
of patients regarding SP
Design and participants 
With the purpose of exploring experiences of patients 
during their participation on SP activities, a qualitative 
study will be conducted through semi-structured 
interviews to patients included in study 1. 
Participants will be recruited during the follow-up 1 or in 
SP appointments. In cases where the patients completed 
the intervention plan or had given up the intervention or 
follow-up, they will be recruited with the cooperation of 
the social worker in contacting and inviting them for the 
study. Selecting patients with different socioeconomic 
characteristics (such as sex, age, employment status 
and migration background) and level of attendance to 
the intervention will help to obtain a diverse sample and 
distinct perspectives on this intervention. 
Both the patients that are still in SP and those who had 
concluded their participation (i.e. who completed the SP 
intervention plan or who gave up the intervention) will 
be included. Those with significant hearing impairments, 
or with insufficient Portuguese/English speaking skills 
(when unaccompanied by a translator) will be excluded 
from participation.
Data collection 
The participants will be contacted via phone call or email 
and invited to participate in a face-to-face interview. 
Interviews will take place in primary healthcare facilities 
or other location according to participants’ preference 
and availability.
A semi-structured guide will be used to conduct the 
interview with patients and will include questions about 
characteristics of the SP intervention, experiences on the 
SP activities performed, perceived changes in lifestyle, 
perspectives about positive and negative aspects of SP, 
opinions on the interactions with healthcare professionals 
and community partners, patient’s satisfaction with the 
SP intervention and suggestions for improvement. All 
interviews will be audio recorded.
Participants will be recruited until no new themes 
emerge from the data collected (data saturation) [30]. 
We estimate to interview 10 to 15 patients in each of the 
Primary Healthcare Units involved in the study. 
Data analysis 
Audio records of the interviews will be transcribed 
verbatim. Participants will revise the transcripts of their 
interviews for validation, to ensure its accuracy. Then, the 
transcripts will be anonymized for storage and scientific 
publication purposes. The transcripts of the interviews 
will be analysed through content analysis technique, as 
described by Bardin [31].
Study 3 – Understanding the perspectives 
of health professionals, social workers and 
community partners on the implementation of SP
Design and participants
Aiming to further understand the implementation of SP a 
qualitative study will be conducted through focus groups 
with health professionals (namely GPs, nurses and 
psychologists), social workers, and community partners 
involved in SP. The focus group technique, through 
group interaction, allows to broaden the understanding 
of the subject under study, its complexity and dynamic 
character, providing rich, valuable information and 
collective perspectives, and has been increasingly used 
in SP evaluation studies [32]. 
Data collection 
In order to get the perspective of the stakeholders who 
have a role in the PS process, and based on the number 
of professionals involved in the SP intervention in Lisbon, 
five focus groups will be conducted: two focus groups 
with health professionals (namely GPs, nurses and 
psychologists), one focus group with social workers, 
and two focus groups with community partners. Each 
focus group will include 6–8 participants, resulting in an 
approximate total of 30 participants. Focus groups will be 
conducted by a moderator and a co-moderator of the 
research team. 
A semi-structured guide will be used, covering 
common topics for all groups regarding perspectives on 
the process of implementing SP, barriers and facilitators, 
suggestions for improvement and experiences of 
collaboration and networking. In addition, each group 
will discuss about topics specifically related to their role 
in the SP intervention. The focus group sessions will be 
audio recorded.
Data analysis 
Audio records of the focus groups will be transcribed 
verbatim. Participants will revise the transcripts of 
their focus group discussion for validation, to ensure 
the accuracy of the transcription. The transcripts will 
be anonymized for storage and scientific publication 
purposes. Content analysis will be performed to analyse 
the data, as described by Bardin [31]. 
Study 4 – Exploring the perceptions of the key 
actors about their networking experience
Participants, data collection and analysis
This study aims to explore the perceptions of the key 
actors involved in SP about their interactions and 
experience of collaboration within the intervention. This 
study draws on data collected in study 2 (interviews 
with patients) and study 3 (focus groups with health 
professionals, social workers, and community partners). 
This study will focus on the collaboration between 
key actors, namely the interactions and exchange of 
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information, the development of new responses, the 
challenges, lessons learned and perceived added value 
of acting in an intersectoral network.
The procedures for data treatment and analysis of the 
interviews and the focus group discussions are described 
in Study 2 and 3, respectively. 
ETHICAL CONSIDERATIONS
Ethical approval for this evaluation study was obtained 
from the Ethics Committee of the Regional Health 
Administration of Lisbon and Tagus Valley (nº 5 2020/
CES/2020).
In all studies, potential participants will be informed 
about the study’s objectives, data collection procedures, 
benefits and potential risks of participation. Participants 
will be assured that their participation in the study is 
voluntary and anonymous, and that the collected data 
is confidential. Participants will also be assured that 
refusing to participate or withdrawing consent at any 
moment will not entail any consequences, nor interfere 
with their participation in SP activities. After each 
participant agrees to participate, he/she will be asked to 
read and sign the informed consent. In study 1, this will 
take place prior to the first SP appointment, and in the 
studies 2 and 3 before the interviews and focus groups, 
respectively.
In study 1, the unique alphanumeric code will ensure 
that participation in the study is anonymous, and only the 
healthcare units’ professional will have the information 
needed to link the codes with patients’ personal 
information (name and contacts). The secondary data 
will be extracted, anonymized, processed and stored 
by the healthcare units’ professional, and then made 
available to the research team.
In studies 2, 3 and 4, an authorization to audio records 
the interviews and focus groups will be requested to 
each participant. The interviews and focus groups will be 
conducted in a private room to ensure the comfort of the 
participants and avoid interruptions.
Electronic data (data bases, computer files) will 
be stored as protected files with exclusive access of 
the research team. Paper-based data (questionnaires 
and consent forms) will be stored in locked cabinets in 
secure offices, only accessible by the research team. The 
identifiable information, such as participants’ names, will 
not be included in the transcriptions. 
DISCUSSION 
This evaluation protocol covers the three major 
dimensions where SP has potential impact: the patients, 
the collaboration between the health and social sectors, 
and the health system. This will be accomplished through 
triangulation of methods and information sources 
(quantitative measures along with in-depth interviews 
and focus groups) based on all key actors’ perspectives. 
Using such a broad evaluation scope will enable to 
obtain a diverse data corpus, allowing to explore in more 
depth the complexity of SP and its effects [33]. In fact, 
due to the interactions that occur between the various 
components of SP, as well as the number of groups 
or organisational levels involved, and the variability 
of outcomes, evaluating this kind of interventions 
implies to consider the context, the characteristics, the 
implementation process, the mechanisms of impact and 
the outcomes of the intervention [34].
In the patient’s dimension, the use of standardized, 
validated and repeated measures throughout time will 
provide a quantitative overview of SP’s contribution to 
individuals’ quality of life, well-being and activation. The 
WEMWBS, EQ-5D and PAM13 scales are the most frequent 
measuring tools used in SP evaluation studies [11, 20]. 
Hence, the application of these scales, validated for the 
Portuguese context, increases the comparability with 
other studies. Furthermore, the number of assessment 
moments and long follow-up duration address 
weaknesses previously pointed out by several authors 
[11, 20, 33], since single and short (up to 4 months post 
intervention) follow-ups have been more commonly 
applied. A long follow-up interval has been considered 
essential to consistently measure the benefits of SP for 
both patients and the health system [17, 35]. 
Moreover, the qualitative study will enable us to 
obtain in-depth insights on the patients’ experiences of 
participation in SP activities. Previous research on impact 
evaluation show that a qualitative approach can reveal 
strong positive narratives about the impact of SP in 
patients’ lives (such as improvements in feelings of well-
being), even if the quantitative outcomes do not reflect 
these improvements (such as improvements in feelings 
of loneliness and social isolation) [19, 20]. 
The SP’s impact on the collaboration between 
the health and social sectors will also be evaluated. 
Specifically, SP interventions and social responses 
provided to patients, and accepted and performed 
by them will be assessed using information from the 
quantitative, longitudinal study. The focus groups will 
provide information on articulation and communication 
between both sectors. Additionally, it will provide an 
insight into the health professionals’, social workers’ and 
community partners’ perspectives, which has only been 
obtained in few studies and remains an important gap in 
the literature regarding SP evaluation [19, 20]. 
More broadly, the collection of information about 
the use of healthcare services will enable an evaluation 
of the influence of SP at the health system level. The 
relevance of assessing SP’s effects on this dimension 
has been previously highlighted [21, 24]. SP responds to 
social needs that often lead patients to seek solutions 
in healthcare services. Thus, by providing effective 
responses to these needs, SP can contribute to reduce 
the overuse of healthcare services and the health 
professionals’ workload. 
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Besides the SP’s impact, this evaluation study also 
intends to provide useful knowledge on its process of 
implementation. The follow-up of all patients referred 
to SP, including those who conclude or withdraw their 
participation from SP activities before the follow-up 
evaluations represents an important innovation of this 
study. This will shed light on barriers to adherence to SP’s 
activities, while also allowing a comparison of outcomes 
between adherent and non-adherent patients. 
Another differential of this evaluation study is that 
information on activities provided by community 
partners, accepted by patients and performed within 
SP will be collected and monitored for each participant. 
This will allow to collect detailed information about each 
patient’s pathway within SP, which has been described as 
a limitation in several studies [11, 17]. It is acknowledged 
that the use of this approach is crucial to understand 
both the scope and the acceptability of the intervention 
among patients [34]. 
Moreover, this evaluation study also covers the 
experience of collaboration and perceived added value 
of intersectoral networks composed of different key 
actors. These topics have not been broadly addressed 
in published studies, and this exchange of information 
between the different levels of service provision – social 
and health sectors – can be valuable for the success of 
the SP intervention [33, 36–38].
An expected limitation of this study is the challenges 
in generalizing the obtained results, since this is an 
evaluation of an SP intervention implemented in a 
local and specific context. The lack of a control group 
is a limitation of the Study 1 and therefore the results 
of this study will need to be interpreted with caution. 
It will be beneficial to conduct controlled studies in 
the future. Another limitation, previously described by 
other authors, is the possible loss of participants in the 
follow-up assessments [19, 20], mainly in the last one 
(12 months) [28, 39]. This possibility can arise from 
difficulties in contacting patients or non-attendance 
to scheduled appointments. Nevertheless, the findings 
of this study can contribute to assist the planning and 
implementation of SP and its evaluation in other contexts 
and countries.
CONCLUSIONS
This study protocol is designed to conduct a robust 
assessment of the SP intervention by addressing 
the limitations pointed out in other studies and by 
comprising the perceptions of the different stakeholders 
involved in the intervention. Although many studies have 
assessed the impact of this intervention in the last years, 
the heterogeneity of study designs and the discrepancy 
of results make it essential to conduct a tailored and 
comprehensive evaluation of the intervention.
The results of this study will provide knowledge on the 
potential impact of the SP intervention for patients, for 
the collaboration between the health and social sector, 
and for the health system in the Portuguese context. 
These results can also contribute to inform practice and 
policy in national and international contexts, and to 
provide insights and learning for the implementation of 
future SP interventions.
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